In vivo analysis of human T-cell leukemia virus type 1 reverse transcription accuracy

Keyphrases

• Human T-cell Leukemia Virus Type 1 (HTLV-1) 100%
• In Vivo Analysis 100%
• Reverse Transcription 100%
• Transcription Accuracy 100%
• Mutation Rate 36%
• Human Immunodeficiency Virus Type 1 (HIV-1) 27%
• Retrovirus 27%
• Virus 18%
• Bovine Leukemia Virus 18%
• In Vivo mutation 18%
• Genetic Diversity 9%
• DNA Replication 9%
• Low Dose Rate 9%
• Cassette 9%
• Valine 9%
• Reverse Transcriptase 9%
• Provirus 9%
• LacZ 9%
• Cellular DNA 9%
• Frameshift mutation 9%
• Mutation Mutation 9%
• Adult T-cell Leukemia 9%
• DNA Replication Origin 9%
• Base Substitution mutations 9%
• Replication Cycle 9%
• Vector System 9%
• Deletion mutation 9%
• Low Diversity 9%
• Methionine Residue 9%
• Bacterial Origin 9%
• Neomycin Phosphotransferase II (npt II) 9%
• One-round 9%
• Frameshift Deletion 9%
• Trans-complementation 9%
• Mutational Target 9%
• Helper Plasmid 9%
• Gene Regions 9%

Immunology and Microbiology

• Human T-Lymphotropic Virus 1 100%
• Reverse Transcription 100%
• Human Immunodeficiency Virus 1 27%
• Mutation Rate 27%
• Retrovirus 27%
• Virus 18%
• Bovine Leukemia Virus 18%
• DNA Synthesis 18%
• Replication 18%
• Provirus 9%
• Genetic Variability 9%
• Plasmid 9%
• Human T Cell Leukemia Virus 9%
• Nucleic Acid Base Substitution 9%
• T Cell 9%
• Reverse Transcriptase 9%
• Frameshift Mutation 9%
• Peptides 9%
• Methionine 9%
• Alanine 9%
• Valine 9%
• Kinase 9%
• Phosphotransferase 9%